European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Pfizer Luxembourg Global Holdings Sàrl, Luxembourg

Watch
Pfizer Luxembourg Global Holdings Sàrl

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €/month

Learn more
Learn more
View plans

Name

Pfizer Luxembourg Global Holdings Sàrl

Identification

Rcsp
RCS B165901
Lei
5493008Z2AOK9ZEPHB56
EUID
LURCSL.B165901

Address

51, Avenue John F. Kennedy, 1855 Luxembourg, Luxembourg

Corporate purpose

64.20
Activities of holding companies

Financial performance

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
4Managing Director
1Manager
1Partner
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Wages and salaries
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Annual report
 
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2016 to 2025
Profit & Loss
from 2016 to 2025
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Publications

17 Jun 2026
Annual report for the year ending 30/11/2025 · Balance sheet for 30/11/2025 · Earnings statement for 30/11/2025
9 Feb 2026
Project of merger / split / transfer of business assets, assets, business division
13 Jan 2026
Managing Director: Maxime Allard · Dismissed: A. Decraene Réginald · Legal form: Société à responsabilité limitée
1 Jul 2025
Annual report for the year ending 30/11/2024 · Balance sheet for 30/11/2024 · Earnings statement for 30/11/2024
9 Jul 2024
Annual report for the year ending 30/11/2023 · Balance sheet for 30/11/2023 · Earnings statement for 30/11/2023
28 Nov 2023 also 27/09/2019, 24/06/2019, 28/01/2019, 28/01/2019, 28/01/2019, 28/01/2019, 28/06/2017, 10/10/2014, 10/06/2013, 15/03/2013
Articles of association
21 Nov 2023
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $3.33B
21 Nov 2023 via Pfizer Luxembourg Sàrl
Shareholding: Pfizer Luxembourg Sàrl
21 Jun 2023
Annual report for the year ending 30/11/2022 · Balance sheet for 30/11/2022 · Earnings statement for 30/11/2022
1 Dec 2022
Managing Director: Magali Koneczny
17 Jun 2022
Annual report for the year ending 30/11/2021 · Balance sheet for 30/11/2021 · Earnings statement for 30/11/2021
18 Mar 2022
Managing Director: J. Heiligenberg · No longer Managing Director: Johannes Hofs
15 Jun 2021
Annual report for the year ending 30/11/2020 · Balance sheet for 30/11/2020 · Earnings statement for 30/11/2020
16 Jun 2020
Annual report for the year ending 30/11/2019 · Balance sheet for 30/11/2019 · Earnings statement for 30/11/2019
2 Jun 2020
Modification, Merger/Demerger
25 May 2020 via Pfizer PFE Norway Holding Sàrl
Shareholding: Pfizer PFE Norway Holding Sàrl
17 Apr 2020
Merger / demerger /professional property and staff transfer project
26 Aug 2019 via Pfizer Luxembourg Sàrl
Shareholding: Pfizer Luxembourg Sàrl
9 Jul 2019 via Pfizer Luxembourg Sàrl
Shareholding: Pfizer Luxembourg Sàrl
9 Jul 2019
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $3.33B
2 Jul 2019
Annual report for the year ending 30/11/2018 · Balance sheet for 30/11/2018 · Earnings statement for 30/11/2018
19 Jun 2019
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $4.56B
19 Jun 2019 via Pfizer Luxembourg Sàrl
Shareholding: Pfizer Luxembourg Sàrl
10 May 2019
Managing Director: Réginald Decraene · No longer Managing Director: S. Savarinayagam
4 Jan 2019
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $4.56B
Year 2018 in Rcsf
Shareholding: Pfizer Luxembourg Sàrl · Shareholding: Pfizer PFE Sweden Holding Sàrl
17 Dec 2018
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $2.41B
12 Dec 2018
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $2.40B
3 Dec 2018
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $2.40B
25 Jun 2018
Annual report for the year ending 30/11/2017 · Balance sheet for 30/11/2017 · Earnings statement for 30/11/2017
23 May 2018
Managing Director: S. Savarinayagam · No longer Managing Director: Adrienn Marton
12 Dec 2017 via Pfizer PFE Sweden Holding Sàrl
Shareholding: Pfizer PFE Sweden Holding Sàrl
5 Dec 2017
No longer Managing Director: S. Savarinayagam
6 Jul 2017
Annual report for the year ending 30/11/2016 · Balance sheet for 30/11/2016 · Earnings statement for 30/11/2016
10 Apr 2017 via Pfizer Luxembourg Sàrl
Shareholding: Pfizer Luxembourg Sàrl
7 Apr 2017
Partner: Pfizer Shareholdings Intermediate Sàrl · Capital: $2.18B
6 Jan 2017 via Pfizer PFE Norway Holding Sàrl
Shareholding: Pfizer PFE Norway Holding Sàrl
1 Dec 2016
Managing Director: Johannes Hofs, S. Savarinayagam · No longer Managing Director: André Petrunoff
4 Aug 2016 also 24/07/2015, 02/07/2014, 20/01/2014
Annual accounts (eCDF)
19 Jan 2016
Manager: Ch. Plantegenet
5 Aug 2015
Managing Director: Adrienn Marton · No longer Managing Director (1)
18 May 2015 via Pfizer Luxembourg Sàrl
Shareholding: Pfizer Luxembourg Sàrl
10 Dec 2014 via Pfizer PFE Luxembourg Holding 1 Sàrl
Shareholding: Pfizer PFE Luxembourg Holding 1 Sàrl
4 Nov 2013 also 19/02/2013, 19/10/2012
Modification
There are no publications matching your search.

Mentions

27 Mar 2026 in Ler
Direct parent
27 Mar 2026 in Ler
Ultimate parent
23 Apr 2024 in Vr
Reg­is­tra­tion: 28/05/1993 · No longer Director (7) · Director (1) · No longer Director: John L.E. Seidler · Change of shareholdings (10 companies) · Capital: 154.9M CZK · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.